glp 1 drug novo nordisk The FDA has approved the first pill version of GLP-1 drugs. says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight Novo Nordisk justifies reasoning behind

and Ernst, E

It will require clinical trials by independent entities to delineate the true effectiveness and side effect profile of this and all new medications. Following the results of earlier trials, Novo Nordisk submitted a New Drug Application to the Food and Drug Administration (FDA) in December 2025 for the use of CagriSema to assist and maintain weight loss alongside diet and exercise adjustments

most are still considered research-only or unapproved new drugs

Winter SC, Zorn EM, Vance WH

Progression to mature cataracts is marked by significant opaque structures occurring in the lens, while hypermature cataracts are those where liquefaction of the lens structure has occurred

Peptides like Selank and Semax, primarily known for their anxiolytic and cognitive effects, may have indirect benefits for psoriasis through stress reduction